Annual Cash & Cash Equivalents
$50.64 M
-$17.17 M-25.32%
31 December 2022
Summary:
Zynerba Pharmaceuticals annual cash & cash equivalents is currently $50.64 million, with the most recent change of -$17.17 million (-25.32%) on 31 December 2022. During the last 3 years, it has fallen by -$8.52 million (-14.40%).ZYNE Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$35.97 M
-$8.43 M-18.99%
30 June 2023
Summary:
Zynerba Pharmaceuticals quarterly cash and cash equivalents is currently $35.97 million, with the most recent change of -$8.43 million (-18.99%) on 30 June 2023.ZYNE Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZYNE Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -14.4% | -52.5% |
| 5 y5 years | -15.3% | -53.6% |
ZYNE Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -27.7% | -61.4% |
Zynerba Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $35.97 M(-19.0%) |
| Mar 2023 | - | $44.40 M(-12.3%) |
| Dec 2022 | $50.64 M(-25.3%) | $50.64 M(-9.5%) |
| Sept 2022 | - | $55.93 M(-10.5%) |
| June 2022 | - | $62.49 M(-10.3%) |
| Mar 2022 | - | $69.70 M(+2.8%) |
| Dec 2021 | $67.81 M(+14.6%) | $67.81 M(-10.4%) |
| Sept 2021 | - | $75.64 M(-11.8%) |
| June 2021 | - | $85.78 M(-7.9%) |
| Mar 2021 | - | $93.13 M(+57.4%) |
| Dec 2020 | $59.16 M(-15.6%) | $59.16 M(-8.0%) |
| Sept 2020 | - | $64.31 M(-16.5%) |
| June 2020 | - | $77.01 M(+27.0%) |
| Mar 2020 | - | $60.64 M(-13.5%) |
| Dec 2019 | $70.06 M(+17.2%) | $70.06 M(-9.7%) |
| Sept 2019 | - | $77.55 M(-12.5%) |
| June 2019 | - | $88.66 M(+29.8%) |
| Mar 2019 | - | $68.30 M(+14.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $59.76 M(-4.4%) | $59.76 M(-9.7%) |
| Sept 2018 | - | $66.18 M(+53.5%) |
| June 2018 | - | $43.12 M(-17.3%) |
| Mar 2018 | - | $52.13 M(-16.6%) |
| Dec 2017 | $62.51 M(+101.9%) | $62.51 M(-5.6%) |
| Sept 2017 | - | $66.25 M(-5.6%) |
| June 2017 | - | $70.18 M(-9.4%) |
| Mar 2017 | - | $77.49 M(+150.3%) |
| Dec 2016 | $30.97 M(-25.4%) | $30.97 M(-2.6%) |
| Sept 2016 | - | $31.78 M(-1.1%) |
| June 2016 | - | $32.13 M(-12.7%) |
| Mar 2016 | - | $36.81 M(-11.3%) |
| Dec 2015 | $41.51 M(+344.9%) | $41.51 M(-7.4%) |
| Sept 2015 | - | $44.81 M(+680.2%) |
| June 2015 | - | $5.74 M(-22.1%) |
| Mar 2015 | - | $7.38 M(-20.9%) |
| Dec 2014 | $9.33 M(+5931.5%) | $9.33 M |
| Dec 2013 | $154.70 K | - |
FAQ
- What is Zynerba Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Zynerba Pharmaceuticals?
- What is Zynerba Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Zynerba Pharmaceuticals?
What is Zynerba Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of ZYNE is $50.64 M
What is the all time high annual cash & cash equivalents for Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals all-time high annual cash & cash equivalents is $70.06 M
What is Zynerba Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ZYNE is $35.97 M
What is the all time high quarterly cash and cash equivalents for Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals all-time high quarterly cash and cash equivalents is $93.13 M